Novel tools for the study of cell type-specific exosomes and microvesicles

Journal of Bioanalysis and Biomedicine

Volumn 4, Issue 4, 2012, Pages 46-60

  Müller, Günter ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biomarkers; Biosensing; Exosomes; Microparticles; Microvesicles; Nanoparticle tracking

Indexed keywords

BIOLOGICAL MARKER; NANOPARTICLE;

ARTICLE; ATOMIC FORCE MICROSCOPY; CELL ASSAY; CELL COMPOSITION; CELL DENSITY; CELL DIFFERENTIATION; CELL ISOLATION; CELL POPULATION; CELL SEPARATION; CELL SIZE; CELL TRACKING; CELL VACUOLE; CENTRIFUGATION; DIAGNOSTIC ACCURACY; DISEASE MARKER; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ENRICHMENT CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; GENETIC PROCEDURES; HUMAN; LIGHT SCATTERING; NANOANALYSIS; NUCLEIC ACID ANALYSIS; PARTICLE SIZE; PHASE CONTRAST MICROSCOPY; PREDICTIVE VALUE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SCANNING ELECTRON MICROSCOPY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

EID: 84867385243     PISSN: None     EISSN: 1948593X     Source Type: Journal    
DOI: 10.4172/1948-593X.1000063     Document Type: Article

References (203)

1. Stoorvogel W, Kleijmeer MJ, Geuze HJ, Raposo G (2002) The biogenesis and functions of exosomes. Traffic 3: 321-330.
2. Cocucci E, Racchetti G, Meldolesi J (2009) Shedding microvesicles: artefacts no more. Trends Cell Biol 19: 43-51.
3. Simons M, Raposo G (2009) Exosomes--vesicular carriers for intercellular communication. Curr Opin Cell Biol 21: 575-581.
4. György B, Szabo TG, Pasztoi M, Pal Z, Misjak P, et al. (2011) Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 68: 2667-2688.
5. Freyssinet JM (2003) Cellular microparticles: What are they bad or good for? J Thromb Haemost 1: 1655-1662.
6. Morel O, Hugel B, Jesel L, Lanza F, Douchet MP, et al. (2004) Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus. Thromb Haemost 91: 345-353.
7. Piccin A, Murphy WG, Smith OP (2007) Circulating microparticles: pathophysiology and clinical implications. Blood Rev 21: 157-171.
8. Muralidharan-Chari V, Clancy JW, Sedgwick A, D'Souza-Schorey C (2010) Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 123: 1603-1611.
9. Lee TH, D'Asti E, Magnus N, Al-Nedawi K, Meehan B, et al. (2011) Microvesicles as mediators of intracellular communication in cancer--the emerging science of cellular 'debris'. Semin Immunopathol 33: 455-467.
10. Record M, Subra C, Silvente-Poirot S, Poirot M (2011) Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol 81: 1171- 1182.
11. Thery C (2011) Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep 3: 15.
12. Booth AM, Fang Y, Fallon JK, Yang YM, Hildreth JE, et al. (2006) Exosomes and HIV gag bud from endosome-like domains of the T cell plasma membrane. J Cell Biol 172: 923-935.
13. Fevrier B, Vilette D, Archer F, Loew D, Faigle W, et al. (2004) Cells release prions in association with exosomes. Proc Natl Acad Sci USA 101: 9683-9688.
14. Welsch S, Keppler OT, Habermann A, Allespach I, Krijnse-Locker J, et al. (2007) HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog 3: e36.
15. Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ (2010) Exosome release of ß-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol 190: 1079-1091.
16. Aupeix K, Hugel B, Martin T, Bischoff P, Lill H, et al. (1997) The significance of shed membrane particles during programmed cell death in vitro and in vivo in HIV-1 infection. J Clin Invest 99: 1546-1554.
17. Thery C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2: 569-579.
18. Brasoveanu LI, Fonsatti E, Visintin A, Pavlovic M, Cattarossi I, et al. (1997) Melanoma cells constitutively release an anchor-positive soluble form of protectin (sCD59) that retains functional activities in homologous complement- mediated cytotoxicity. J Clin Invest 100: 1248-1255.
19. Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, et al. (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cells- derived exosomes. Nat Med 4: 594-600.
20. Blanchard N, Lankar D, Faure F, Regnault A, Dumont C, et al. (2002) TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol 168: 3235-3241.
21. Laulagnier K, Motta C, Hamdi S, Roy S, Fauvelle F, et al. (2004) Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem J 380: 161-171.
22. Martinez MC, Kunzelmann C, Freyssinet JM (2004) Plasma membrane remodelling and cell stimulation. Med Sci 20: 189-195.
23. Hogan MC, Manganelli L, Woollard JR, Masyuk AI, Masyuk TV, et al. (2009) Characterization of PKD protein-positive exosome-like vesicles. J Am Soc Nephrol 20: 278-288.
24. Müller G (2010) Control of lipid storage and cell size between adipocytes by vesicle-associated glycosylphosphatidylinositol-anchored proteins. Arch Physiol Biochem 117: 23-43.
25. Müller G, Wied S, Jung C, Over S (2008) Translocation of glycosylphosphatidylinositol-anchored proteins to lipid droplets and inhibition of lipolysis in rat adipocytes is mediated by reactive oxygen species. Br J Pharmacol 154: 901-913.
26. Müller G, Wied S, Straub J, Jung C (2008) Coordinated regulation of esterification and lipolysis by palmitate, H2O2 and the anti-diabetic sulfonylurea drug, glimepiride, in rat adipocytes. Eur J Pharmacol 597: 6-18.
27. Müller G, Wied S, Dearey E-A, Biemer-Daub G (2011) Glycosylphosphatidylinositol-anchored proteins coordinate lipolysis inhibition between large and small adipocytes. Metabolism 60: 1021-1037.
28. Müller G (2012) Microvesicles/Exosomes as Potential Novel Biomarkers for Metabolic Diseases. Diab Metab Syn Obesity: Targets Ther 5: 247-282.
29. Cheruvanky A, Zhou H, Pisitkun T, Kopp JB, Knepper MA, et al. (2007) Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. Am J Physiol Renal Physiol 292: F1657-F1661.
30. Conde-Vancells J, Rodriguez-Suarez E, Gonzalez E, Berisa A, Gil D, et al. (2010) Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples. Proteomics Clin Appl 4: 416-425.
31. Miranda KC, Bond DT, McKee M, Skog J, Pǎunescu TG, et al. (2010) Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int 78: 191-199.
32. Simak J, Gelderman MP (2006) Cell membrane microparticles in blood and blood products: Potentially pathogenic agents and diagnostic markers. Transfus Med Rev 20: 1-26.
33. Pisitkun T, Shen RF, Knepper MA (2004) Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 101: 13368-13373.
34. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3: e3694.
35. Taylor DD, Gercel-Taylor C (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110: 13-21.
36. Michael A, Bajracharya SD, Yuen PS, Zhou H, Star RA, et al. (2010) Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 16: 34-38.
37. Keller S, Ridinger J, Rupp AK, Janssen JW, Altevogt P (2011) Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med 9: 86.
38. Dowling P, Clynes M (2011) Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of disease-specific biomarkers. Proteomics 11: 794-804.
39. Lathia CD (2002) Biomarkers and surrogate endpoints: How and when they might impact drug development. Dis Markers 18: 83-90.
40. Colburn WA (2003) Biomarkers in drug discovery and development: from target identification through drug marketing. J Clin Pharmacol 43: 329-341.
41. Naylor S (2003) Biomarkers: Current perspectives and future prospects. Expert Rev Mol Diagn 3: 525-529.
42. Zolg JW, Langen H (2004) How industry is approaching the search for new diagnostic markers and biomarkers. Mol Cell Proteomics 3: 345-354.
43. Ciesla M, Skrzypek K, Kozakowska M, Loboda A, Jozkowicz A, et al. (2011) MicroRNAs as biomarkers of disease onset. Anal Bioanal Chem 401: 2051-2061.
44. Lee JM, Han JJ, Altwerger G, Kohn EC (2011) Proteomics and biomarkers in clinical trials for drug development. J Proteomics 74: 2632-2641.
45. Zineh I, Huang SM (2011) Biomarkers in drug development and regulation: a paradigm for clinical implementation of personalized medicine. Biomark Med 5: 705-713.
46. Müller G (2012) Novel target Identification technologies for the personalised therapy of type II diabetes and obesity. Immunol Endocr Metabol Agents Med Chem 12: 183-207.
47. Kolberg JA, Jorgensen T, Gerwien RW, Hamren S, McKenna MP, et al. (2009) Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes Care 32: 1207-1212.
48. Schulze MB, Weikert C, Pischon T, Bergmann MM, Al-Hasani H, et al. (2009) Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: the EPIC-Potsdam study. Diabetes Care 32: 2116-2119.
49. Herder C, Karakas M, Koenig W (2011) Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther 90: 52-66.
50. Younus S, Rodgers G (2011) Biomarkers associated with cardiometabolic risk in obesity. Am Heart Hosp J 9: E28-E32.
51. Lyons TJ, Basu A (2012) Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers. Transl Res 159: 303-312.
52. Bonauer A, Boon RA, Dimmeler S (2010) Vascular microRNAs. Curr Drug Targets 11: 943-949.
53. Dignat-George F, Boulanger CM (2011) The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 31: 27-33.
54. Martinez MC, Andriantsitohaina R (2011) Microparticles in angiogenesis: therapeutic potential. Circ Res 109: 110-119.
55. Siljander PR (2011) Platelet-derived microparticles - an updated perspective. Thromb Res 127: S30-S33.
56. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, et al. (2001) Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104: 2649-2652.
57. Nomura S, Tandon NN, Nakamura T, Cone J, Fukuhara S, et al. (2001) High- shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis 158: 277-287.
58. Bernal-Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, et al. (2003) High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 145: 962-970.
59. Ferreira AC, Peter AA, Mendez AJ, Jimenez JJ, Mauro LM, et al. (2004) Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation 110: 3599-3603.
60. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, et al. (2003) Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109: 175-180.
61. Preston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, et al. (2003) Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 41: 211-217.
62. Horstman LL, Jy W, Jimenez JJ, Ahn YS (2004) Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 9: 1118-1135.
63. Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS (2004) Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 286: H1910-H1915.
64. Nomura S, Shouzu A, Omoto S, Hayakawa T, Kagawa H, et al. (1998) Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes. Thromb Haemost 80: 388-392.
65. Tan KT, Tayebjee MH, Lim HS, Lip GY (2005) Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels. Diabet Med 22: 1657-1662.
66. Esposito K, Ciotola M, Giugliano D (2006) Pioglitazone reduces endothelial microparticles in the metabolic syndrome. Arterioscler Thromb Vasc Biol 26: 1926.
67. Setzer F, Oberle V, Bläss M, Möller E, Ruswurm S, et al. (2006) Platelet- derived microvesicles induce differential gene expression in monocytic cells: a DNA microarray study. Platelets 17: 571-576.
68. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, Mostefai HA, Draunet-Busson C, et al. (2008) Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 173: 1210-1219.
69. Freyssinet JM, Toti F (2010) Formation of procoagulant microparticles and properties. Thromb Res 1: S46-S48.
70. Nomura S, Suzuki M, Katsura K, Xie GL, Miyazaki Y, et al. (1995) Platelet- derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 116: 235-240.
71. Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JW, et al. (2002) Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 106: 2442-2447.
72. Omoto S, Nomura S, Shouzu A, Nishikawa M, Fukuhara S, et al. (2002) Detection of monocyte-derived microparticles in patients with type II diabetes mellitus. Diabetologia 45: 550-555.
73. Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, et al. (2002) Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 51: 2840-2845.
74. Esposito K, Maiorino MI, Di Palo C, Gicchino M, Petrizzo M, et al. (2011) Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes--a randomized controlled trial. Diabetes Obes Metab 13: 439-445.
75. Esposito K, Ciotola M, Schisano B, Gualdiero R, Sardelli L, et al. (2006) Endothelial microparticles correlate with endothelial dysfunction in obese women. J Clin Endocrinol Metab 91: 3676-3679.
76. Goichot B, Grunebaum L, Desprez D, Vinzio S, Meyer L, et al. (2006) Circulating procoagulant microparticles in obesity. Diabetes Metab 32: 82-85.
77. Koga H, Sugiyama S, Kugiyama K, Fukushima H, Watanabe K, et al. (2006) Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease. Eur Heart J 27: 817-823.
78. Leroyer AS, Tedgui A, Boulanger CM (2008) Microparticles and type 2 diabetes. Diabetes Metab 34: S27-S31.
79. Helal O, Defoort C, Robert S, Marin C, Lesavre N, et al. (2011) Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress. Nutr Metab Cardiovasc Dis 21: 665-671.
80. Tramontano AF, Lyubarova R, Tsiakos J, Palaia T, Deleon JR, et al. (2010) Circulating endothelial microparticles in diabetes mellitus. Mediators Inflamm 2010: 250476.
81. Horstman LL, Jy W, Minagar A, Bidot CJ, Jimenez JJ, et al. (2007) Cell- derived microparticles and exosomes in neuroinflammatory disorders. Int Rev Neurobiol 79: 227-268.
82. Mitchell PJ, Welton J, Staffurth J, Court J, Mason MD, et al. (2009) Can urinary exosomes act as treatment response markers in prostate cancer? J Transl Med 7: 4.
83. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH (2009) Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 10: 42-46.
84. Simpson RJ, Lim JW, Moritz RL, Mathivanan S (2009) Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics 6: 267-283.
85. Qazi KR, Torregrosa Paredes P, Dahlberg B, Grunewald J, Eklund A, et al. (2010) Proinflammatory exosomes in bronchoalveolar lavage fluid of patients with sarcoidosis. Thorax 65: 1016-1024.
86. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Zembala M (2007) Tumour-derived microvesicles modulate biological activity of human monocytes. Immunol Lett 113: 76-82.
87. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, et al. (2007) Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110: 2440- 2448.
88. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, et al. (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10: 1470-1476.
89. Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J (2009) Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A 106: 3794-3799.
90. Yuan A, Farber EL, Rapoport AL (2009) Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One 4: e4722.
91. Castellana D, Toti F, Freyssinet JM (2010) Membrane microvesicles: Macromessengers in cancer disease and progression. Thromb Res 125: S84-S88.
92. Liu Y, Xiang X, Zhuang X, Zhang S, Liu C, et al. (2010) Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells. Am J Pathol 176: 2490-2499.
93. Kogure T, Lin WL, Yan IK, Braconi C, Patel T (2011) Intercellular nanovesicle- mediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 54: 1237-1248.
94. Yang M, Chen J, Su F, Yu B, Su F, et al. (2011) Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 10: 117.
95. Morel NM, Holland JM, van der Greef J, Marple EW, Clish C, et al. (2004) Introduction to systems biology - A new approach to understanding disease and treatment. Mayo Clin Proc 79: 651-658.
96. Naylor S (2005) Systems biology, information, disease and drug discovery. Drug Discovery World 6: 23-33.
97. Chung J, Nguyen AK, Henstridge DC, Holmes AG, Chan MH, et al. (2008) HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci U S A 105: 1739-1744.
98. Gehrmann M, Liebisch G, Schmitz G, Anderson R, Steinem C, et al. (2008) Tumor-specific Hsp70 plasma membrane localization is enabled by the glycosphingolipid Gb3. PLoS One 3: e1925.
99. Vigh L, Horvath I, Maresca B, Harwood JL (2007) Can the stress protein response be controlled by 'membrane-lipid therapy'? Trends Biochem Sci 32: 357-363.
100. Stangl S, Gehrmann M, Riegger J, Kuhs K, Riederer I, et al. (2011) Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHSP70.1 antibody. Proc Natl Acad Sci U S A 108: 733-738.
101. Xie Y, Bai O, Zhang H, Yuan J, Zong S, et al. (2010) Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70. J Cell Mol Med 14: 2655-2666.
102. Peter M, Balogh G, Gombos I, Liebisch G, Horvath I, et al. (2012) Nutritional lipid supply can control the heat shock response of B16 melanoma cells in culture. Mol Membr Biol in press.
103. Schmitz G, Grandl M (2008) Update on lipid membrane microdomains. Curr Opin Clin Nutr Metab Care 11: 106-112.
104. Babiychuk EB, Atanassoff AP, Monastyrskaya K, Brandenberger C, Studer D, et al. (2011) The targeting of plasmalemmal ceramide to mitochondria during apoptosis. PLoS One 6: e23706.
105. Babiychuk EB, Monastyrskaya K, Potez S, Draeger A (2011) Blebbing confers resistance against cell lysis. Cell Death Differ 18: 80-90.
106. Potez S, Luginbühl M, Monastyrskaya K, Hostettler A, Draeger A, et al. (2011) Tailored protection against plasmalemmal injury by annexins with different Ca2+ sensitivities. J Biol Chem 286: 17982-17991.
107. Draeger A (2011) The targeting of plasmalemmal ceramide to mitochondria during apoptosis. PLoS One 6: e23706.
108. Draeger A, Monastyrskaya K, Babiychuk EB (2011) Plasma membrane repair and cellular damage control: the annexin survival kit. Biochem Pharmacol 81: 703-712.
109. Babiychuk EB, Draeger A (2006) Biochemical characterization of detergent- resistant membranes: a systematic approach. Biochem J 397: 407-416.
110. Horstman LL, Jy W, Jimenez JJ, Bidot C, Ahn YS (2004) New horizons in the analysis of circulating cell-derived microparticles. Keio J Med 53: 210-230.
111. Soo CY, Song Y, Zheng Y, Cambell EC, Riches AC, et al. (2012) Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells. Immunology 136: 192-197.
112. Coren LV, Shatzer T, Ott DE (2008) CD45 immunoaffinity depletion of vesicles from Jurkat T cells demonstrates that exosomes contain CD45: no evidence for a distinct exosome/HIV-1 budding pathway. Retrovirology 5: 64.
113. Momen-Heravi F, Balaj L, Alian S, Trachtenberg AJ, Hochberg FH, et al. (2012) Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles. Front Physiol 3: 162.
114. Tauro BJ, Greening DW, Mathias RA, Ji H, Mathivanan S, et al. (2012) Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 56: 293-304.
115. Jayachandran M, Miller VM, Heit JA, Owen WG (2012) Methodology for isolation, identification and characterization of microvesicles in peripheral blood. J Immunol Methods 375: 207-214.
116. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, et al. (1996) B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183: 1161-1172.
117. Thery C, Amigorena S, Raposo G, Clayton A (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protocols Cell Biol 3: 221-229.
118. Taylor DD, Lyons KS, Gercel-Taylor C (2002) Shed membrane fragment- associated markers for endometrial and ovarian cancers. Gynecol Oncol 84: 443-448.
119. Sokolova V, Ludwig A-K, Hornung S, Rotan O, Horn PA, et al. (2011) Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Coll Surf B Biointerf 87: 146-150.
120. Jy W, Horstman LL, Ahn YS (2010) Microparticle size and its relation to composition, functional activity, and clinical significance. Semin Thromb Hemost 36: 876-880.
121. Lawrie AS, Albanyan A, Cardigan RA, Mackie IJ, Harrison P (2009) Microparticle sizing by dynamic light scattering in fresh-frozen plasma. Vox Sanguinis 96: 206-212.
122. Grant R, Ansa-Addo E, Stratton D, Antwi-Baffour S, Jorfi S, et al. (2011) A filtration-based protocol to isolate human plasma membrane-derived vesicles and exosomes from blood plasma. J Immunol Meth 371: 143-151.
123. Sharma S, Rasool HI, Palanisamy V, Mathisen C, Schmidt M, et al. (2010) Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. ACS Nano 4: 1921-1926.
124. Yuana Y, Oosterkamp TH, Bahatyrova S, Ashcroft B, Garcia Rodriguez P, et al. (2010) Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. J Thromb Haemost 8: 315-323.
125. van der Pol E, Hoekstra AG, Sturk A, Otto C, van Leeuwen TG, et al. (2010) Optical and non-optical methods for detection and characterisation of microparticles and exosomes. J Thromb Haemost 8: 2596-2607.
126. Perez-Pujol S, Marker PH, Key NS (2007) Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry Part A 71: 38-45.
127. Abusamra AJ, Zhong Z, Zheng X, Li M, Ichim TE, et al. (2005) Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol Dis 35: 169-173.
128. Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, et al. (2002) Induction of lymphcyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 195: 1303-1316.
129. Palma J, Yaddanapudi SC, Pigati L, Havens MA, Jeong S, et al. (2012) MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Res.
130. Bala S, Petrasek J, Mundkur S, Catalano D, Levin I, et al. (2012) Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced and inflammatory liver diseases. Hepatology in press.
131. Gallo A, Tandon M, Alevizos I, Illei GG (2012) The majority of microRNAs is detectable in serum and saliva is concentrated in exosomes. PLoS One 7: e30679.
132. Lässer C, Eldh M, Lötvall J (2012) Isolation and characterization of RNA- containing exosomes. J Vis Exp 59: e3037.
133. Zhou Q, Li M, Wang X, Li Q, Wang T, et al. (2012) Immune-related microRNAs are abundant in breast milk exosomes. Int J Biol Sci 8: 118-123.
134. Rani S, O'Brien K, Kelleher FC, Corcoran C, Germano S, et al. (2011) Isolation of exosomes for subsequent mRNA, microRNA, and protein profiling. Methods Mol Biol 784: 181-195.
135. Taylor DD, Zacharias W, Gercel-Taylor C (2011) Exosome isolation for proteomic analyses and RNA profiling. Methods Mol Biol 728: 235-246.
136. Michael A, Bajracharya SD, Yuen PS, Zhou H, Star RA, et al. (2010) Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 16: 34-38.
137. Rosell R, Wei J, Taron M (2009) Circulating microRNA signatures of tumor- derived exosomes for early diagnosis of non-small-cell lung cancer. Clin Lung Cancer 10: 8-9.
138. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, et al. (2007) Exosome- mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659.
139. Ehrenschwender T, Wagenknecht H-A (2011) 4,4-Difluoro-4-bora-3a, 4a-diaza-s-indacene as a bright fluorescent label for DNA. J Org Chem 76: 2301-2304.
140. Ehrenschwender T, Varga BR, Kele P, Wagenknecht H-A (2010) New infra- red and near-infrared fluorescent probes with large Stockes shifts for dual covalent labeling of DNA. Chem Asian J 5: 1761-1764.
141. Holzhauser C, Berndl S, Menacher F, Breunig M, Göpferich A, et al. (2010) Synthesis and optical properties of cyanine dyes as fluorescent DNA base substitutions for live cell imaging. Eur J Org Chem 39: 1239-1248.
142. Holzhauser C, Wagenknecht H-A (2011) In-stem labeled molecular beacons for distinct fluorescent color readout. Angew Chem Int Ed 50: 7268-7272.
143. Berndl S, Breunig M, Göpfering A, Wagenknecht H-A (2010) Imaging of RNA delivery to cells by thiazole orange as a fluorecent RNA base substituent. Org Biomol Chem 8: 997-999.
144. Berndl S, Herzig N, Kele P, Lachmann D, Li X, et al. (2009) Comparison of a nucleosidic vs. a non-nucleosidic postsynthetic "Click" modification of DNA with base-labil fluorescent probes. Bioconjugate Chem 20: 558-564.
145. Carr B, Hole P, Malloy A, Nelson P, Wright M, et al. (2009) Application of nanoparticle tracking analysis in nanoparticle research - a mini-review. Eur J Parent Pharm Sci 14: 35-40.
146. Filipe V, Hawe A, Jiskoot W (2010) Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res 27: 796-810.
147. Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, et al. (2011) Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomedicine NBM 7: 780-788.
148. Lacroix R, Robert S, Poncelet P, Dignat-George F (2010) Overcoming the limitations of microparticle measurement by flow cytometry. Semin Thromb Haemost 36: 807-818.
149. Lacroix R, Robert S, Poncelet P, Kasthuri RS, Key NS, et al. (2010) Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 8: 2571-2574.
150. Foladori P, Quaranta A, Ziglio G (2008) Use of silica microspheres having refractive index similar to bacteria for conversion of flow cytometric forward light scanner into biovolume. Water Res 42: 3757-3766.
151. Orozco AF, Lewis DE (2010) Flow cytometric analysis of circulating microparticles in plasma. Cytometry Part A 77: 502-514.
152. Webber J, Steadman R, Mason MD, Tabi Z, Clayton A (2010) Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res 70: 9621-9630.
153. Reddy A, Zhong XY, Rusterholz C, Hahn S, Holzgreve W, et al. (2008) The effect of labour and placental separation on the shedding of syncytiotrophoblast microparticles, cell-free DNA and mRNA in normal pregnancy and pre- eclampsia. Placenta 29: 942-949.
154. Ruf H, Gould BJ (1998) Size distribution of chylomicrons from human lymph from dynamic light scattering measurements. Eur Biophys J 28: 1-11.
155. Cantero M, Conejo S, Parra T, Jimenez A, Carbello F, et al. (1998) Interference of chylomicrons in analysis of platelets by flow cytometry. Thromb Res 91: 49-52.
156. Aschner M (2009) Chapter 8 - Nanoparticles: Transport across the olfactory epithelium and application to the assessment of brain function in health and disease. Prog Brain Res 180: 141-152.
157. Garcia-Garcia E, Gil S, Andrieux K, Desmaele D, Nicolas V, et al. (2005) A relevant in vitro rat model for the evalution of blood-brain barrier translocation of nanoparticles. Cell Mol Life Sci 62: 1400-1408.
158. Elder A, Vidyasagar S, DeLouise L (2009) Physicochemical factors that affect metal and metal oxide nanoparticle passage across epithelial barriers. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1: 434-450.
159. Bouwmeester H, Poortman J, Peters RJ, Wijma E, Kramer E, et al. (2011) Characterization of translocation of silver nanoparticles and effects on whole-genome gene expression using an in vitro intestinal epithelium coculture model. ACS Nano 5: 4091-4103.
160. De M, Rana S, Akpinar H, Miranda OR, Arvizo RR, et al. (2009) Sensing of proteins in human serum using conjugates of nanoparticles and green fluorescent protein. Nat Chem 1: 461-465.
161. Anslyn EV, Rotello VM (2010) Chemosensory models: approaches and applications of differential sensing. Curr Opin Chem Biol 14: 683-684.
162. Miranda OR, Creran B, Rotello VM (2010) Array-based sensing with nanoparticles: 'chemical noses' for sensing biomolecules and cell surfaces. Curr Opin Chem Biol 14: 728-736.
163. Müller G (2012) (Glycosylphosphatidylinositol-based) protein chips and biosensors for biopharmaceutical process analytics. J Bioprocess Biotec 2: 115.
164. Müller G (2011) Glycosylphosphatidylinositol-Anchored protein chips for patient-tailored multi-parameter proteomics. J Biochips Tiss chip S3:001.
165. Müller G, Jung C, Straub J, Wied S (2009) Induced release of membrane vesicles and exosomes from rat adipocytes containing lipid droplet, lipid raft and glycosylphosphatidylinositol-anchored proteins. Cell Signal 21: 324-338.
166. Müller G, Wied S, Jung C, Biemer-Daub G, Frick W (2010) Transfer of glycosylphosphatidylinositol-anchored 5'-nucleotidase CD73 from adiposomes into rat adipocytes stimulates lipid synthesis. Br J Pharmacol 160: 878-891.
167. Müller G, Wied S, Jung C, Frick W, Biemer-Daub G (2010) Inhibition of lipolysis by adiposomes containing glycosylphosphatidylinositol-anchored Gce1 protein in rat adipocytes. Arch Physiol Biochem 116: 28-41.
168. Müller G, Schneider M, Biemer-Daub G, Wied S (2011) Upregulation of lipid synthesis in small rat adipocytes by microvesicle-associated CD73 from large adipocytes. Obesity (Silver Spring) 19: 1531-1544.
169. Müller G, Schneider M, Biemer-Daub G, Wied S (2011) Microvesicles released from rat adipocytes and harboring glycosylphosphatidylinositol-anchored proteins transfer RNA stimulating lipid synthesis. Cell Signal 23: 1207-1223.
170. Müller G, Jung C, Wied S, Biemer-Daub G (2009) Induced translocation of glycosylphosphatidylinositol-anchored proteins from lipid droplets to adiposomes in rat adipocytes. Br J Pharmacol 158: 749-770.
171. Müller G, Schneider M, Gassenhuber J, Wied S (2012) Release of exosomes and microvesicles harbouring specific RNAs and glycosylphosphatidylinositol- anchored proteins from rat and human adipocytes is controlled by histone methylation. Am J Mol Biol 2: 187-209.
172. Aoki N, Jin-no S, Nakagawa Y, Asai N, Arakawa E, et al. (2007) Identification and characterization of microvesicles secreted by 3T3-L1 adipocytes: redox- and hormone-dependent induction of milk fat globule-epidermal growth factor 8-associated microvesicles. Endocrinology 148: 3850-3862.
173. Ogawa R, Tanaka C, Sato M, Nagasaki H, Sugimura K, et al. (2010) Adipocyte- derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation. Biochem Biophys Res Commun 398: 723-729.
174. Qu Y, Franchi L, Nunez G, Dubyak GR (2007) Nonclassical IL-1 beta secretion stimulation by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. I Immunol 179: 1913-1925.
175. Napoletano C, Rughetti A, Landi R, Pinto D, Bellati F, et al. (2009) Immunogenicity of allo-vesicle carrying ERBB2 tumor antigen for dendritic cell-based anti-tumor immunotherapy. Int J Immunopathol Pharmacol 22: 647-658.
176. Taylor DD, Gercel-Taylor C (2011) Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Semin Immunopathol 33: 441-454.
177. Minagar A, Jy W, Jimenez JJ, Sheremata WA, Mauro LM, et al. (2001) Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 56: 1319-1324.
178. Kim HK, Song KS, Park YS, Kang YH, Lee YJ, et al. (2003) Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer. Possible role of a metastasis predictor. Eur J Cancer 39: 184-191.
179. Eilertsen KE, Osterud B (2005) The role of blood cells and their microparticles in blood coagulation. Biochem Soc Trans 33: 418-422.
180. Marzesco AM, Janich P, Wilsch-Bräuninger M, Dubreuil V, Langenfeld K, et al. (2005) Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD33) from neural progenitors and other epithelial cells. J Cell Sci 118: 2849-2858.
181. Yuana Y, Bertina RM, Osanto S (2011) Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 105: 396-408.
182. Jayachandran M, Miller VM, Heit JA, Owen WG (2012) Methodology for isolation and characterization of microvesicles in peripheral blood. J Immunol Meth 375: 207-214.
183. Trummer A, De Rop C, Tiede A, Ganser A, Eisert R (2009) Recovery and composition of microparticles after snap-freezing depends on thawing temperature. Blood Coagul Fibrinolysis 20: 52-56.
184. Zhang Y, Li Y, Qiu F, Qiu Z (2010) Comprehensive analysis of low-abundance proteins in human urinary exosomes using peptide ligand library technology, peptide OFFGEL fractionation and nanoHPLC-chip-MS/MS. Electrophoresis 31: 3797-3807.
185. Wang Z, Hill S, Luther JM, Hachey DL, Schey KL (2012) Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT). Proteomics 12: 329-338.
186. Moon PG, You S, Lee JE, Hwang D, Baek MC (2011) Urinary exosomes and proteomics. Mass Spectrom Rev 30: 1185-1202.
187. Dey-Hazra E, Hertel B, Kirsch T, Woywodt A, Lovric S, et al. (2010) Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing. Vasc Health Risk Manag 6: 1125-1133.
188. Mrvar-Brecko A, Sustar V, Jansa V, Stukelj R, Jansa R, et al. (2010) Isolated microvesicles from peripheral blood and body fluids as observed by scanning electron microscope. Blood Cells Mol Dis 44: 307-312.
189. Leong HS, Podor TJ, Manocha B, Lewis JD (2011) Validation of flow cytometric detection of platelet microparticles and liposomes by atomic force microscopy. J Thromb Haemost 9: 2466-2476.
190. Holme PA, Solum NO, Brosstad F, Roger M, Abdelnoor M (1994) Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting. Thromb Haemost 72: 666-671.
191. Turchinovich A, Weiz L, Langheinz A, Burwinkel B (2011) Characterization of extracellular microRNA. Nucleic Acids Res 39: 7223-7233.
192. Merchant ML, Powell DW, Wilkey DW, Cummins TD, Deegens JK, et al.(2010) Microfiltration isolation of human urinary exosomes for characterization by MS. Proteomics Clin Appl 4: 84-96.
193. Pattanapanyasat K, Noulsri E, Fucharoen S, Lerdwana S, Lamchiagdhase P, et al. (2004) Flow cytometric quantitation of red blood cell vesicles in thalassemia. Cytometry B Clin Cytom 57: 23-31.
194. van der Pol E, Van Gemmert MJ, Sturk A, Nieuwland R, Van Leeuwen TG (2012) Single vs. swarm detection of microparticles and exosomes by flow cytometry. J Thromb Haemost 10: 919-930.
195. Robert S, Poncelet P, Lacroix R, Arnaud L, Giraudo L, et al. (2009) Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? J Thromb Haemost 7: 190-197.
196. Matic GB, Rothe G, Schmitz G (2011) Flow cytometric analysis of reticulated platelets. Curr Protoc Cytom.
197. Shah MD, Bergeron AL, Dong JF, Lopez JA (2008) Flow cytometric measurement of microparticles: pitfalls and protocol modifications. Platelets 19: 365-372.
198. Trummer A, De Rop C, Tiede A, Ganser A, Eisert R (2008) Isotype controls in phenotyping and quantification of microparticles: a major source of error and how to evade it. Thromb Res 122: 691-700.
199. Chandler WL, Yeung W, Tait JF (2011) A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer. J Thromb Haemost 9: 1216-1224.
200. Mullier F, Bailly N, Chatelain C, Dogne JM, Chatelain B (2011) More on calibration for the measurement of microparticles: needs, interests, and limitations of calibrated polystyrene beads for flow cytometry-based quantification of biological microparticles. J Thromb Haemost 9: 1679-1681.
201. Lvovich V, Srikanthan S, Silverstein RL (2010) A novel broadband impedance method for detection of cell-derived microparticles. Biosens Bioelectron 26: 444-451.
202. Chen C, Skog J, Hsu C-H, Lessard RT, Balaj L, et al. (2010) Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip 10: 505-511.
203. Hind E, Heugh S, Ansa-Addo EA, Antwi-Baffour S, Lange S, et al. (2010) Red cell PMVs, plasma membrane-derived vesicles calling out for standards. Biochem Biophys Res Commun 399: 465-490.